Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix vs LHRH Agonists in Prostate Cancer with CV Disease
NCT02475057Phase 4Completed
- Sponsor
- Rabin Medical Center
- Start
- Aug 2015
- Primary completion
- Jul 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of degarelix in prostate cancer (PCa), sponsored by Rabin Medical Center. Started Aug 2015; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02475057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02475057.